Arq Bras Endocrinol Metabol, Vol. 49, No. 5. (October 2005), pp. 613-614.
J Natl Cancer Inst, Vol. 92, No. 10. (17 May 2000)
Clin Chem, Vol. 48, No. 8. (August 2002), pp. 1147-1150.
NeuroRx, Vol. 1, No. 2. (April 2004), pp. 189-195.
Toxicol Pathol, Vol. 32 Suppl 1 (r 2004), pp. 116-121.
Mol Cell Proteomics, Vol. 3, No. 4. (April 2004), pp. 345-354.
Toxicol Pathol, Vol. 32 Suppl 1 (r 2004), pp. 1-2.
Clin Chem, Vol. 50, No. 5. (May 2004), pp. 793-795.
IARC Sci Publ, No. 157. (2004), pp. 437-450.
Mol Pharm, Vol. 3, No. 1. (b 2006), pp. 26-32.
Pharmacogenomics, Vol. 7, No. 1. (January 2006), pp. 117-122.
AAPS J, Vol. 8, No. 1. (2006)
Ther Drug Monit, Vol. 28, No. 1. (February 2006), pp. 35-38.
Pharm Res, Vol. 23, No. 2. (February 2006), pp. 312-328.
by JW
Lee, V
Devanarayan, YC
Barrett, R
Weiner, J
Allinson, S
Fountain, S
Keller, I
Weinryb, M
Green, L
Duan, JA
Rogers, R
Millham, PJ
O'Brien, J
Sailstad, M
Khan, C
Ray, JA
Wagner
Expert Rev Proteomics, Vol. 3, No. 1. (February 2006), pp. 45-62.
Eur J Clin Pharmacol, Vol. 62, No. 2. (February 2006), pp. 91-95.
Nippon Yakurigaku Zasshi, Vol. 127, No. 3. (March 2006), pp. 217-221.
J Proteome Res, Vol. 5, No. 3. (March 2006), pp. 461-462.
Expert Review of Molecular Diagnostics, Vol. 6, No. 2. (March 2006), pp. 179-191.
Mol Cell Proteomics (17 March 2006)
Biochem Soc Trans, Vol. 34, No. Pt 2. (April 2006), pp. 313-316.
Nature Reviews Drug Discovery, Vol. 5, No. 5. (21 April 2006), pp. 377-380.
Proteomics, Vol. 6, No. 10. (May 2006), pp. 2947-2958.
Nature, Vol. 441, No. 7092. (24 May 2006), pp. 451-456.
Mol Cell Proteomics (29 May 2006)
Drug Discov Today, Vol. 11, No. 11-12. (June 2006), pp. 550-555.
Curr Pharm Biotechnol, Vol. 7, No. 3. (June 2006), pp. 147-158.
Curr Drug Metab, Vol. 7, No. 5. (June 2006), pp. 525-539.
J Clin Pharmacol, Vol. 43, No. 4. (April 2003), pp. 329-341.
J Endocrinol, Vol. 186, No. 1. (July 2005), pp. 1-20.
Mol Pharmacol, Vol. 67, No. 5. (May 2005), pp. 1383-1384.
Biochem J, Vol. 385, No. Pt 3. (1 February 2005), pp. 625-637.
Br J Pharmacol, Vol. 143, No. 2. (September 2004), pp. 235-245.
Mol Pharmacol, Vol. 66, No. 1. (July 2004), pp. 1-7.
Curr Opin Drug Discov Devel, Vol. 4, No. 5. (September 2001), pp. 561-574.
Biochem J, Vol. 374, No. Pt 2. (1 September 2003), pp. 281-296.
Annu Rev Physiol, Vol. 65 (2003), pp. 851-879.
Pharmacol Rev, Vol. 54, No. 2. (June 2002), pp. 323-374.
J Am Osteopath Assoc, Vol. 105, No. 9. (September 2005), pp. 409-416.
Folia Neuropathol, Vol. 43, No. 3. (2005), pp. 193-196.
NeuroRx, Vol. 1, No. 2. (April 2004), pp. 182-188.
NeuroRx, Vol. 2, No. 4. (October 2005), pp. 683-695.
NeuroRx, Vol. 2, No. 4. (October 2005), pp. 579-589.
NeuroRx, Vol. 2, No. 4. (October 2005), pp. 627-637.
Nat Biotech, Vol. 22, No. 10. (October 2004), pp. 1249-1252.
Proteome Science, Vol. 4, No. 1. (04 April 2006), 5.
The EMBO Journal, Vol. aop, No. current. (27 January 2005)
The Journal of Physiology, Vol. 563, No. 1. (February 2005), pp. 11-21.
J Exp Bot, Vol. 56, No. 410. (January 2005), pp. 245-254.